Takeda secures phishing site in UDRP dispute
Pharmaceutical company Takeda has recovered a domain name that is confusingly similar to its trademark.
The domain, takedapharmaceuticalsusa.com, was registered in February this year, 52 years after Takeda first registered its ‘Takeda’ trademark in the US.
It led Takeda to file a complaint under the Uniform Domain Name Dispute Resolution Policy with the US-based National Arbitration Forum (NAF) on March 22.
Takeda argued that the respondent, Rejeev Venkayya, had used its mark in connection with the company, that the domain is confusingly similar, that the respondent has no rights or legitimate interests in it, and that it isn’t offering “bona fide” goods or services.
The respondent did not reply to the complaint.
In a decision dated April 20 and published today, April 26, NAF panellist Bruce Meyerson handed Takeda the domain name.
He said it was confusingly similar to Takeda’s trademark “as it incorporates the mark in its entirety while adding the generic term ‘pharmaceuticals’ the geographic term ‘USA’ and the gTLD ‘.com’”.
Further, he said that the respondent does not have permission, authorisation or consent to use’s Takeda’s mark and has no rights or legitimate interests in it.
He also said that the respondent “uses the email address associated with the domain … to pass itself off as complainant and phish for internet users’ sensitive personal and/or financial information”.
The respondent also “scours job boards”, sends “recruiting” emails for an online interview and “requests personal” information from individuals and therefore did not legitimately or fairly use the domain.
“Further, the record shows that respondent is attempting to trick internet users into divulging personal information … Respondent invites internet users to a Google HangOut, where respondent asks users to provide sensitive personal or financial information,” Meyerson said.
The decision is available here.
This was first published on Trademarks and Brands Online.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk